Skip to content
10-Q

Quarterly Report

EMMAUS LIFE SCIENCES, INC. EMMA

0000950170-25-072520

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 10, 2025 63.87M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $1.33M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $1.39M
Current Liabilities Q1 2025 · Mar 31, 2025 $64.92M
Current Liabilities Q1 2025 · Dec 31, 2024 $63.56M
Total Liabilities Q1 2025 · Mar 31, 2025 $81.08M
Total Liabilities Q1 2025 · Dec 31, 2024 $80.08M
Current Assets Q1 2025 · Mar 31, 2025 $5.65M
Current Assets Q1 2025 · Dec 31, 2024 $6.77M
Total Assets Q1 2025 · Mar 31, 2025 $22.48M
Total Assets Q1 2025 · Dec 31, 2024 $23.6M
Shares Diluted Q1 2025 · Mar 31, 2024 61.85M sh
Capex Q1 2025 · Mar 31, 2024 $4K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $140K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$53.64M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$47.76M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.07
Eps Basic Q1 2025 · Mar 31, 2024 −$0.07
Sga Expense Q1 2025 · Mar 31, 2024 $2.87M
Rd Expense Q1 2025 · Mar 31, 2024 $183K
Net Income Q1 2025 · Mar 31, 2024 −$4.35M
Operating Income Q1 2025 · Mar 31, 2024 −$2.74M
Gross Profit Q1 2025 · Mar 31, 2024 $2.25M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $257K
Revenue Q1 2025 · Mar 31, 2024 $2.51M